Results 21 to 30 of about 838,554 (221)
Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance [PDF]
Clinical Infectious Diseases, 2015 With an increase in the use of colistin methansulfonate (CMS) to treat carbapenem-resistant Acinetobacter baumannii infections, colistin resistance is emerging.Patients with infection or colonization due to colistin-resistant A. baumannii were identified at a hospital system in Pennsylvania. Clinical data were collected from electronic medical records.
Zubair A, Qureshi +8 more
openaire +2 more sources
Early dissemination of OXA-72-producing Acinetobacter baumannii strain in Colombia: a case report
Brazilian Journal of Infectious Diseases, 2014 Nosocomial infections caused by carbapenem-resistant Acinetobacter baumannii isolates have reached epidemic levels in past decades. Currently this microorganism is responsible for outbreaks of difficult eradication and with high mortality rates worldwide.
Sandra Yamile Saavedra +4 more
doaj +1 more source
Biofilm formation and biocide resistance of acinetobacter baumannii [PDF]
Multi drug resistant (MDR) strains of Acinetobacter baumannii have emerged as a major cause of nosocomial infections associated with significant morbidity and mortality.
Shoukat, Kamran
core +3 more sources
Antibiotics, 2021 Treatment of infections caused by Acinetobacter spp., particularly A. baumannii, is a major clinical problem due to its high rates of antibiotic resistance.
Cristina Lasarte-Monterrubio +9 more
doaj +1 more source
Frontiers in Immunology, 2017 Acinetobacter baumannii, an opportunistic ESKAPE pathogen, causes respiratory and urinary tract infections. Its prevalence increases gradually in the clinical setup.
Vishvanath Tiwari +2 more
doaj +1 more source
Frontiers in Cellular and Infection Microbiology, 2022 ObjectivesThe spread of antibiotic resistant bacteria is an important threat for human health. Acinetobacter baumannii bacteria impose such a major issue, as multidrug- to pandrug-resistant strains have been isolated, rendering some infections ...
Anke Breine +14 more
doaj +1 more source
Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment [PDF]
Clinical Microbiology and Infection, 2019 Carbapenem-resistant Acinetobacter baumannii (CRAB) has gained global notoriety as a critically important nosocomial pathogen. It mostly affects debilitated patients, causing pneumonia and bloodstream infections with high mortality rates. Difficulties in treating CRAB infections stem from a formidable resistance profile that leaves available only a few
Piperaki, E.-T. +3 more
openaire +3 more sources
The transmission of nosocomial pathogens in an intensive care unit: a space–time clustering and structural equation modelling approach [PDF]
, 2010 We investigated the incidence of cases of nosocomial pathogens and risk factors in an intensive treatment unit ward to determine if the number of cases is dependent on location of patients and the colonization/infection history of the ward.
Sheridan, E. A. +4 more
core +1 more source
Journal of Infection in Developing Countries, 2009 Acinetobacter baumannii is an opportunistic gram-negative pathogen with increasing relevance in a variety of nosocomial infections especially among intensive-care-unit (ICU) patients. Carbapenems have been widely used to treat serious multidrug-resistant
Raffaele Zarrilli +4 more
doaj +1 more source
Investigation of the prevalence and role of mobile genetic elements associated with an aminoglycoside resistance gene, aacC2a, in Acinetobacter baumannii [PDF]
, 2009 Includes abstract. Includes bibliographical references (leaves 115-141)
Jongwe, Tsungai Ivai
core +1 more source